Ghost Tree Capital as of March 31, 2022
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 41 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 49.0 | $226M | 500k | 451.64 | |
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 5.9 | $27M | 300k | 89.88 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.6 | $16M | 140k | 117.36 | |
| Cogent Biosciences (COGT) | 2.8 | $13M | 1.7M | 7.49 | |
| Apellis Pharmaceuticals (APLS) | 2.8 | $13M | 250k | 50.81 | |
| Merus N V (MRUS) | 2.3 | $11M | 400k | 26.44 | |
| Amicus Therapeutics (FOLD) | 2.3 | $10M | 1.1M | 9.47 | |
| Sierra Oncology Com New | 2.3 | $10M | 325k | 32.05 | |
| Celldex Therapeutics Com New (CLDX) | 2.2 | $10M | 300k | 34.06 | |
| Axsome Therapeutics (AXSM) | 2.2 | $10M | 245k | 41.39 | |
| Miragen Therapeutics (VRDN) | 1.9 | $8.6M | 466k | 18.49 | |
| Karuna Therapeutics Ord | 1.7 | $7.6M | 60k | 126.78 | |
| Iveric Bio | 1.6 | $7.6M | 450k | 16.83 | |
| Arvinas Ord (ARVN) | 1.6 | $7.4M | 110k | 67.30 | |
| Vaxcyte (PCVX) | 1.6 | $7.2M | 300k | 24.15 | |
| Kezar Life Sciences (KZR) | 1.4 | $6.6M | 400k | 16.62 | |
| Cti Biopharma | 1.3 | $6.1M | 1.3M | 4.67 | |
| BioCryst Pharmaceuticals (BCRX) | 1.2 | $5.7M | 350k | 16.26 | |
| Rapt Therapeutics (RAPT) | 1.2 | $5.5M | 250k | 21.99 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.0 | $4.4M | 100k | 43.88 | |
| Syndax Pharmaceuticals (SNDX) | 0.8 | $3.9M | 225k | 17.38 | |
| Sarepta Therapeutics (SRPT) | 0.8 | $3.9M | 50k | 78.12 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.8 | $3.7M | 750k | 4.99 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.8 | $3.7M | 80k | 46.14 | |
| Design Therapeutics (DSGN) | 0.7 | $3.2M | 200k | 16.15 | |
| Rocket Pharmaceuticals (RCKT) | 0.7 | $3.2M | 200k | 15.86 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $3.1M | 100k | 30.57 | |
| Relmada Therapeutics (RLMD) | 0.6 | $2.7M | 100k | 26.99 | |
| Aadi Bioscience (AADI) | 0.6 | $2.5M | 150k | 16.97 | |
| Aclaris Therapeutics (ACRS) | 0.5 | $2.2M | 125k | 17.24 | |
| Tarsus Pharmaceuticals (TARS) | 0.4 | $2.0M | 120k | 16.82 | |
| 9 Meters Biopharma | 0.4 | $1.9M | 3.3M | 0.60 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.4 | $1.9M | 85k | 21.95 | |
| Satsuma Pharmaceuticals Ord | 0.4 | $1.8M | 474k | 3.80 | |
| Leap Therapeutics | 0.4 | $1.7M | 994k | 1.75 | |
| Mirati Therapeutics | 0.4 | $1.6M | 20k | 82.20 | |
| Vistagen Therapeutics Com New | 0.4 | $1.6M | 1.3M | 1.24 | |
| Aeglea Biotherapeutics | 0.3 | $1.6M | 687k | 2.30 | |
| Pardes Biosciences | 0.1 | $614k | 85k | 7.22 | |
| Larimar Therapeutics (LRMR) | 0.1 | $405k | 100k | 4.05 | |
| Pyxis Oncology Common Stock (PYXS) | 0.1 | $303k | 75k | 4.04 |
